Vyant Bio (NASDAQ:VYNT) Inc (NASDAQ:VYNT) CEO Jay Roberts talks to Proactive about a new partnership with MASORI Therapeutics, a company focused on the pharmaceutical industry and applying artificial intelligence to achieve competitive advantage through the creation of innovative market solutions.
Roberts says under the agreement, the two companies will pursue co-development and out-licensing partnerships with pharmaceutical and biotechnology companies in the Japanese market.